The results of a retrospective study involving 44 EGFR-mutant NSCLC who received concurrent radiotherapy and TKI [93], recorded frequent and severe AEs with two patients that had to discontinue the treatment due to grade ≥ 3 cutaneous toxicity [93]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.